Previous close | 32.91 |
Open | 32.85 |
Bid | 32.57 x 51100 |
Ask | 32.68 x 25600 |
Day's range | 32.49 - 32.89 |
52-week range | 21.14 - 35.30 |
Volume | |
Avg. volume | 2,320,185 |
Market cap | 48.619B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | 32.94 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.30 (0.90%) |
Ex-dividend date | 08 May 2024 |
1y target est | N/A |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.